4//SEC Filing
PROLOR Biotech, Inc. 4
Accession 0001144204-13-049006
CIK 0001268659operating
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:40 PM ET
Size
13.6 KB
Accession
0001144204-13-049006
Insider Transaction Report
Form 4
GORECKI MARIAN
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2013-08-29−15,000→ 0 totalExercise: $0.65Exp: 2019-02-05→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-08-29−40,000→ 0 totalExercise: $5.47Exp: 2021-08-04→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-08-29−44,000→ 0 totalExercise: $4.74Exp: 2023-02-04→ Common Stock (44,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-08-29−25,000→ 0 totalExercise: $0.93Exp: 2018-03-01→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]Pursuant to an Agreement and Plan of Merger, dated as of April 23, 2013 (the "Merger Agreement"), by and among the Issuer, OPKO Health, Inc. ("OPKO") and POM Acquisition, Inc. ("POM"), a wholly-owned subsidiary of OPKO formed for the purpose of facilitating the merger of POM with and into the Issuer (the "Merger"), this option, which vested in 3 equal annual installments beginning on March 4, 2009, was assumed by OPKO at the effective time of the Merger and replaced with an option to purchase 24,877 shares of common stock, par value $0.01 per share, of OPKO ("OPKO Common Stock") at an exercise price of $0.94 per share.
- [F2]Pursuant to the Merger Agreement, this option, which vested in 1 installment on February 5, 2010, was assumed by OPKO at the effective time of the Merger and replaced with an option to purchase 14,926 shares of OPKO Common Stock at an exercise price of $0.66 per share.
- [F3]Pursuant to the Merger Agreement, this option, which vested in 1 installment on August 4, 2012, was assumed by OPKO at the effective time of the Merger and replaced with an option to purchase 39,804 shares of OPKO Common Stock at an exercise price of $5.50 per share.
- [F4]Pursuant to the Merger Agreement, this option, which provided for vesting in 12 equal monthly installments beginning on March 4, 2013, was assumed by OPKO at the effective time of the Merger and replaced with an option to purchase 43,784 shares of OPKO Common Stock at an exercise price of $4.77 per share. In addition, pursuant to the stock option agreement governing this option, at the effective time of the Merger this option became fully vested and exercisable.
Documents
Issuer
PROLOR Biotech, Inc.
CIK 0001268659
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001268659
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:40 PM ET
- Size
- 13.6 KB